Catalyst Wire Dossier Catalyst Wire Dossier

18F-Fluciclatide

Fluciclatide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 18F-Fluciclatide, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors [Phase 1, Phase 2]

See pricing